These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Inhibition of MPTP-induced α-synuclein oligomerization by fatty acid-binding protein 3 ligand in MPTP-treated mice. Matsuo K; Cheng A; Yabuki Y; Takahata I; Miyachi H; Fukunaga K Neuropharmacology; 2019 May; 150():164-174. PubMed ID: 30930168 [TBL] [Abstract][Full Text] [Related]
9. FABP3 protein promotes α-synuclein oligomerization associated with 1-methyl-1,2,3,6-tetrahydropiridine-induced neurotoxicity. Shioda N; Yabuki Y; Kobayashi Y; Onozato M; Owada Y; Fukunaga K J Biol Chem; 2014 Jul; 289(27):18957-65. PubMed ID: 24855640 [TBL] [Abstract][Full Text] [Related]
10. Fatty Acid-Binding Protein 3 Expression in the Brain and Skin in Human Synucleinopathies. Oizumi H; Yamasaki K; Suzuki H; Hasegawa T; Sugimura Y; Baba T; Fukunaga K; Takeda A Front Aging Neurosci; 2021; 13():648982. PubMed ID: 33841128 [TBL] [Abstract][Full Text] [Related]
11. Novel FABP3 ligand, HY-11-9, ameliorates neuropathological deficits in MPTP-induced Parkinsonism in mice. Wang H; Fukunaga K; Cheng A; Wang Y; Arimura N; Yoshino H; Sasaki T; Kawahata I J Pharmacol Sci; 2023 May; 152(1):30-38. PubMed ID: 37059489 [TBL] [Abstract][Full Text] [Related]
12. Impact of fatty acid-binding proteins and dopamine receptors on α-synucleinopathy. Kawahata I; Fukunaga K J Pharmacol Sci; 2022 Feb; 148(2):248-254. PubMed ID: 35063140 [TBL] [Abstract][Full Text] [Related]
13. [Role of fatty acid-binding protein 7 and novel therapeutic approach in synucleinopathies]. Cheng A; Fukunaga K Nihon Yakurigaku Zasshi; 2022; 157(6):396-400. PubMed ID: 36328545 [TBL] [Abstract][Full Text] [Related]
14. Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's disease model mice. Haga H; Yamada R; Izumi H; Shinoda Y; Kawahata I; Miyachi H; Fukunaga K Pharmacol Biochem Behav; 2020 Apr; 191():172891. PubMed ID: 32126223 [TBL] [Abstract][Full Text] [Related]
15. Effects of Alpha-Synuclein Targeted Antisense Oligonucleotides on Lewy Body-Like Pathology and Behavioral Disturbances Induced by Injections of Pre-Formed Fibrils in the Mouse Motor Cortex. Boutros SW; Raber J; Unni VK J Parkinsons Dis; 2021; 11(3):1091-1115. PubMed ID: 34057097 [TBL] [Abstract][Full Text] [Related]
16. Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson's Disease. Huang R; Gao Y; Duan Q; Zhang Q; He P; Chen J; Ma G; Wang L; Zhang Y; Nie K; Wang L Mol Neurobiol; 2023 Feb; 60(2):979-1003. PubMed ID: 36394710 [TBL] [Abstract][Full Text] [Related]
17. α-Synuclein (αSyn) Preformed Fibrils Induce Endogenous αSyn Aggregation, Compromise Synaptic Activity and Enhance Synapse Loss in Cultured Excitatory Hippocampal Neurons. Wu Q; Takano H; Riddle DM; Trojanowski JQ; Coulter DA; Lee VM J Neurosci; 2019 Jun; 39(26):5080-5094. PubMed ID: 31036761 [TBL] [Abstract][Full Text] [Related]
18. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein. Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536 [TBL] [Abstract][Full Text] [Related]
19. Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration. Wang X; Becker K; Levine N; Zhang M; Lieberman AP; Moore DJ; Ma J Acta Neuropathol Commun; 2019 Mar; 7(1):41. PubMed ID: 30871620 [TBL] [Abstract][Full Text] [Related]
20. Dopamine D2 Long Receptors Are Critical for Caveolae-Mediated α-Synuclein Uptake in Cultured Dopaminergic Neurons. Kawahata I; Sekimori T; Wang H; Wang Y; Sasaoka T; Bousset L; Melki R; Mizobata T; Kawata Y; Fukunaga K Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33429895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]